PubRank

D N Lockwood

Author PubWeight™ 28.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The preregistration year: Chaos by consensus. Lancet 1977 2.50
2 Medical-school admission policies. Lancet 1979 1.66
3 Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol 1995 1.50
4 The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000 1.40
5 Leprosy: a 'common' and curable cause of peripheral neuropathy with skin lesions. J R Coll Physicians Edinb 2015 1.39
6 Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2002 1.37
7 Rapid diagnosis of Falciparum malaria by using the ParaSight F test in travellers returning to the United Kingdom: prospective study. BMJ 2000 1.25
8 Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun 2001 1.24
9 Treatment of visceral leishmaniasis. J Glob Infect Dis 2010 1.12
10 Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions. Clin Exp Immunol 1998 0.99
11 The management of erythema nodosum leprosum: current and future options. Lepr Rev 1996 0.95
12 Revaccination with BCG: its effects on skin tests in Kuwaiti senior school children. Eur Respir J 1990 0.90
13 Leprosy in England and Wales. Commun Dis Public Health 1999 0.88
14 Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae. Infect Immun 1999 0.83
15 Recognition of a category of responders to group II, slow-grower associated antigens amongst Kuwaiti senior school children, using a statistical model. Tubercle 1988 0.82
16 Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence? Lepr Rev 1997 0.82
17 Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Trop Med Int Health 2009 0.82
18 Student audit of clinical teaching: a three year study. Br Med J (Clin Res Ed) 1985 0.81
19 Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel. J R Army Med Corps 2005 0.81
20 New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate. Trans R Soc Trop Med Hyg 2004 0.81
21 DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. Respir Physiol 1991 0.80
22 Never take things at face value. Lancet 1998 0.80
23 Nerve and skin damage in leprosy is associated with increased intralesional heat shock protein. Clin Exp Immunol 1994 0.79
24 Glucocorticoids as a novel approach to the treatment of disabling side effects of sodium stibogluconate. J Clin Pharm Ther 2011 0.79
25 Leprosy in the new millennium. J Med Microbiol 2000 0.78
26 Immunohistochemical detection of PGL-1, LAM, 30 kD and 65 kD antigens in leprosy infected paraffin preserved skin and nerve sections. Lepr Rev 1999 0.76
27 Clinical experience of clerks and dressers: a three-year study of Birmingham medical students. J R Soc Med 1986 0.75
28 Update on leprosy. Hosp Med 2001 0.75
29 Leprosy--new perspectives on an old disease. J Infect 1999 0.75
30 Decline of the first M.B. Lancet 1978 0.75
31 Surgical dressers: the theatre experience of junior clinical students. Med Educ 1986 0.75
32 Blood donation and risk of cardiovascular disease. Lancet 1981 0.75
33 A pilot study of three potential vaccines for leprosy in Bombay. Int J Lepr Other Mycobact Dis 1989 0.75